Ramos Esquivel, A. E., Hernández Steller, H., Savard, M., & Landaverde Recinos, D. (2018). Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: A systematic review and meta-analysis of phase III randomized clinical trials.
Παραπομπή Chicago StyleRamos Esquivel, Allan Eduardo, Hellen Hernández Steller, Marie-France Savard, και Denis Landaverde Recinos. Cyclin-dependent Kinase 4/6 Inhibitors As First-line Treatment for Post-menopausal Metastatic Hormone Receptor-positive Breast Cancer Patients: A Systematic Review and Meta-analysis of Phase III Randomized Clinical Trials. 2018.
Παραπομπή MLARamos Esquivel, Allan Eduardo, Hellen Hernández Steller, Marie-France Savard, και Denis Landaverde Recinos. Cyclin-dependent Kinase 4/6 Inhibitors As First-line Treatment for Post-menopausal Metastatic Hormone Receptor-positive Breast Cancer Patients: A Systematic Review and Meta-analysis of Phase III Randomized Clinical Trials. 2018.